These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17149863)

  • 21. Synthesis and biological evaluation of a series of aromatic bisphosphonates.
    Barney RJ; Wasko BM; Dudakovic A; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2010 Oct; 18(20):7212-20. PubMed ID: 20832326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
    Dunford JE; Thompson K; Coxon FP; Luckman SP; Hahn FM; Poulter CD; Ebetino FH; Rogers MJ
    J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacophoric studies of in vitro inhibition of Plasmodium falciparum growth.
    Hariharan S
    Indian J Biochem Biophys; 2012 Apr; 49(2):101-8. PubMed ID: 22650007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acylated sulfonamide congeners of fosmidomycin lack any inhibitory activity against DXR.
    Gadakh B; Pouyez J; Wouters J; Venkatesham A; Cos P; Van Aerschot A
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1577-9. PubMed ID: 25726328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human farnesyl pyrophosphate synthase inhibition by nitrogen bisphosphonates: a 3D-QSAR study.
    Fernández D; Ortega-Castro J; Frau J
    J Comput Aided Mol Des; 2013 Aug; 27(8):739-54. PubMed ID: 23979193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A quantitative structure-activity relationship and pharmacophore modeling investigation of aryl-X and heterocyclic bisphosphonates as bone resorption agents.
    Kotsikorou E; Oldfield E
    J Med Chem; 2003 Jul; 46(14):2932-44. PubMed ID: 12825934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D-QSAR, molecular docking, and ONIOM studies on the structure-activity relationships and action mechanism of nitrogen-containing bisphosphonates.
    Liu QZ; Wang SS; Li X; Zhao XY; Li K; Lv GC; Qiu L; Lin JG
    Chem Biol Drug Des; 2018 Mar; 91(3):735-746. PubMed ID: 29080272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of potent bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase via targeted interactions with the active site 'capping' phenyls.
    De Schutter JW; Shaw J; Lin YS; Tsantrizos YS
    Bioorg Med Chem; 2012 Sep; 20(18):5583-91. PubMed ID: 22884353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase.
    Yin F; Cao R; Goddard A; Zhang Y; Oldfield E
    J Am Chem Soc; 2006 Mar; 128(11):3524-5. PubMed ID: 16536518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitrogen-containing bisphosphonates as carbocation transition state analogs for isoprenoid biosynthesis.
    Martin MB; Arnold W; Heath HT; Urbina JA; Oldfield E
    Biochem Biophys Res Commun; 1999 Oct; 263(3):754-8. PubMed ID: 10512752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DXR inhibition by potent mono- and disubstituted fosmidomycin analogues.
    Jansson AM; Więckowska A; Björkelid C; Yahiaoui S; Sooriyaarachchi S; Lindh M; Bergfors T; Dharavath S; Desroses M; Suresh S; Andaloussi M; Nikhil R; Sreevalli S; Srinivasa BR; Larhed M; Jones TA; Karlén A; Mowbray SL
    J Med Chem; 2013 Aug; 56(15):6190-9. PubMed ID: 23819803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between the chemistry and biological activity of the bisphosphonates.
    Ebetino FH; Hogan AM; Sun S; Tsoumpra MK; Duan X; Triffitt JT; Kwaasi AA; Dunford JE; Barnett BL; Oppermann U; Lundy MW; Boyde A; Kashemirov BA; McKenna CE; Russell RG
    Bone; 2011 Jul; 49(1):20-33. PubMed ID: 21497677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thienopyrimidine bisphosphonate (ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: optimization and characterization of the mode of inhibition.
    Leung CY; Park J; De Schutter JW; Sebag M; Berghuis AM; Tsantrizos YS
    J Med Chem; 2013 Oct; 56(20):7939-50. PubMed ID: 23998921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a bisphosphonate that inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase.
    Thompson K; Dunford JE; Ebetino FH; Rogers MJ
    Biochem Biophys Res Commun; 2002 Jan; 290(2):869-73. PubMed ID: 11785983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of new potent inhibitors of farnesyl pyrophosphate synthase.
    Prokopenko V; Kovalishyn V; Shevchuk M; Kopernyk I; Metelytsia L; Romanenko V; Mogilevich S; Kukhar V
    Curr Drug Discov Technol; 2014 Jun; 11(2):133-44. PubMed ID: 24818603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Isoprenoid pigments in representatives of the family Microbacteriaceae].
    Trutko SM; Dorofeeva LV; Evtushenko LI; Ostrovskiĭ DN; Hintz M; Wiesner J; Jomaa H; Baskunov BP; Akimenko VK
    Mikrobiologiia; 2005; 74(3):335-41. PubMed ID: 16119846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved efficacy of fosmidomycin against Plasmodium and Mycobacterium species by combination with the cell-penetrating peptide octaarginine.
    Sparr C; Purkayastha N; Kolesinska B; Gengenbacher M; Amulic B; Matuschewski K; Seebach D; Kamena F
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4689-98. PubMed ID: 23856773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivatives.
    Messiaen AS; Verbrugghen T; Declerck C; Ortmann R; Schlitzer M; Nelis H; Van Calenbergh S; Coenye T
    Int J Antimicrob Agents; 2011 Sep; 38(3):261-4. PubMed ID: 21724375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-bisphosphonate inhibitors of isoprenoid biosynthesis identified via computer-aided drug design.
    Durrant JD; Cao R; Gorfe AA; Zhu W; Li J; Sankovsky A; Oldfield E; McCammon JA
    Chem Biol Drug Des; 2011 Sep; 78(3):323-32. PubMed ID: 21696546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.